3 Results for "

latent PAI-1

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "latent PAI-1" in MCE Product Catalog:

  • Targets Recommended:
Cat. No.: HY-117724
CAS No.: 1418747-15-5
Purity:  98.03%
Target:  

PAI-1

Research Areas:  

Cardiovascular Disease

AZ3976 is a potent plasminogen activator inhibitor type 1 (PAI-1) inhibitor with an IC50 value of 26 μM in an enzymatic chromogenic assay. AZ3976 is active with an IC50 of 16 μM in a plasma clot lysis assay. AZ3976 does not bind to active PAI-1 but bound reversibly to latent PAI-1. AZ3976 inhibits PAI-1 by enhancing the latency transition of active PAI-1. AZ3976 displays profibrinolytic activities in a human plasma clot lysis assay .
loading...
    loading...
Cat. No.: HY-165084
CAS No.: 383908-63-2
Synonyms: Soy PS sodium
L-α-Phosphatidylserine sodium (Soy PS sodium) is a negatively charged phospholipid that acts as an allosteric activator to activate latent plasminogen activator inhibitor-1 (PAI-1). L-α-Phosphatidylserine does not directly alter the catalytic activity of t-PA, but regulates fibrinolytic activity solely by inducing conformational remodeling of PAI-1. L-α-Phosphatidylserine sodium is an antigen targeting phosphatidylserine (PS) and can induce the production of polyclonal antibodies. L-α-Phosphatidylserine is mainly used in studies related to immunology, fibrinolytic system and coagulation homeostasis .
loading...
    loading...
Cat. No.: HY-P992313

Target:  

PAI-1

Research Areas:  

Cardiovascular Disease

AS3288802, a highly selective active plasminogen activator inhibitor-1 (PAI-1) antibody, is a PAI-1 inhibitor with a human IC50 and EC50 values of 4.2 ng/mL. AS3288802 can be used for the research of thrombosis and fibrosis-related diseases .
loading...
    loading...